Funding and Reimbursement Sessions at ISCT 2009
May 04, 2009
Dr. Dawn Driscoll of DCi Biotech will Chair and present at two sessions during the International Society for Cellular Therapy (ISCT) annual meeting to be held May 3-6, 2009 in San Diego, California. Sessions will include "Pharmaceutical Perspectives on Cell Therapies: Participation and Partnering," along with Mr. Jeff Karan of Proteus Venture Partners, Dr. Tom Novak of Roche, and Mr. Ken Aldridge of International Stem Cell Corporation. Dr. Driscoll will also present on "Corporate and Clinical Strategies for Evidence-Based Reimbursement Strategies," along with Dr. Sarah Haecker from Haecker Consulting and Mr. Antonio Montecalvo from Organogenesis. Select presentations from these sessions are available on www.celltherapysociety.org.
